News and events
- All
- Events
- Press releases
- Publications
All
- All
- Events
- Press releases
- Publications
Bio€quity Europe— May 12-14, 2023 – Dublin, Ireland
Excited to be a part of the Presenting Company Class
March 27, 2023
Read More
ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19
ExeVir Bio and VIB-UGent’s bioRxiv pre-print reports on S2-binding camelid
March 13, 2023
Read More
ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank
xeVir Bio, a biotech company developing robust nanobody therapies for
January 9, 2023
Read More
Bio Partnering at JPM — January 9-12, 2023 – San Francisco, CA
ExeVir is a clinical-stage company developing novel antibody therapies that
January 5, 2023
Read More
ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors
ExeVir is pleased to announce today the appointment of Dr
October 20, 2022
Read More